Moleculin Biotech Inc
NASDAQ:MBRX
Moleculin Biotech Inc
NASDAQ:MBRX
Price:
2.68
USD
-44.28%
Market Closed
Market Cap:
$7.2m
Balance Sheet
Balance Sheet Decomposition
Moleculin Biotech Inc
Moleculin Biotech Inc
Balance Sheet Decomposition is not available for
Moleculin Biotech Inc
Moleculin Biotech Inc
Balance Sheet
Moleculin Biotech Inc
Moleculin Biotech Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
1
|
0
|
5
|
8
|
7
|
11
|
15
|
71
|
43
|
24
|
4
|
|
| Cash Equivalents |
1
|
0
|
5
|
8
|
7
|
11
|
15
|
71
|
43
|
24
|
4
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
3
|
2
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
1
|
0
|
5
|
8
|
8
|
13
|
17
|
72
|
46
|
26
|
5
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
0
-96%
|
16
+58 446%
|
19
+19%
|
20
+1%
|
25
+29%
|
29
+15%
|
84
+190%
|
57
-32%
|
38
-33%
|
17
-56%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
2
|
1
|
2
|
2
|
3
|
4
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
1
|
1
|
2
|
4
|
4
|
3
|
4
|
5
|
7
|
5
|
|
| Long-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
6
|
8
|
1
|
0
|
5
|
6
|
|
| Total Liabilities |
3
N/A
|
1
-76%
|
1
+85%
|
2
+65%
|
5
+125%
|
10
+82%
|
11
+17%
|
5
-55%
|
5
+3%
|
12
+132%
|
11
-10%
|
|
| Equity | ||||||||||||
| Common Stock |
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
14
|
1
|
5
|
14
|
26
|
40
|
57
|
73
|
102
|
132
|
153
|
|
| Additional Paid In Capital |
0
|
0
|
20
|
32
|
41
|
55
|
75
|
152
|
154
|
158
|
159
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
1
+70%
|
15
N/A
|
17
+14%
|
14
-17%
|
16
+9%
|
18
+14%
|
79
+345%
|
52
-34%
|
26
-50%
|
6
-77%
|
|
| Total Liabilities & Equity |
1
N/A
|
0
-96%
|
16
+58 446%
|
19
+19%
|
20
+1%
|
25
+29%
|
29
+15%
|
84
+190%
|
57
-32%
|
38
-33%
|
17
-56%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
